Earnings Per Share, Diluted of Vistagen Therapeutics, Inc. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Vistagen Therapeutics, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending 31 Dec 2025 was -0.45, a 2.2% increase year-over-year.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Diluted for the twelve months ending 31 Dec 2025 was -1.9, a 104% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2024 was -1.67, a 9.9% decline from 2023.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2023 was -1.52, a 82% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2022 was -8.51.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Vistagen Therapeutics, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -1.9 -0.45 +0.01 +2.2% 01 Oct 2025 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 -1.91 -0.54 -0.12 -29% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2026 Q2
Q2 2025 -1.79 -0.47 -0.12 -34% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 -1.67 -0.44 -0.74 -247% 01 Jan 2025 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q4 2024 -0.93 -0.46 -0.24 -109% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2026 2026 Q3
Q3 2024 -0.69 -0.42 +0.24 +36% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2026 Q2
Q2 2024 -0.93 -0.35 +0.59 +63% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q1 2024 -1.52 0.3 01 Jan 2024 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 -0.22 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q3
Q3 2023 -0.66 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 -0.94 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2025 Q1
Q4 2015 -1.95 -0.87 -81% 01 Oct 2015 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 -5.26 -3.36 -177% 01 Jul 2015 30 Sep 2015 10-Q 16 Nov 2015 2016 Q2
Q1 2015 -10.92 -4.24 -2.67 -170% 01 Jan 2015 31 Mar 2015 10-K 24 Jun 2016 2016 FY
Q4 2014 -8.25 -1.08 -0.64 -145% 01 Oct 2014 31 Dec 2014 10-K 24 Jun 2016 2016 FY
Q3 2014 -7.61 -1.9 -0.53 -39% 01 Jul 2014 30 Sep 2014 10-K 24 Jun 2016 2016 FY
Q2 2014 -7.08 -3.7 -3.26 -741% 01 Apr 2014 30 Jun 2014 10-K 24 Jun 2016 2016 FY
Q1 2014 -3.82 -1.57 -1.38 -726% 01 Jan 2014 31 Mar 2014 10-K 29 Jun 2015 2015 FY
Q4 2013 -2.44 -0.44 +0.41 +48% 01 Oct 2013 31 Dec 2013 10-K 29 Jun 2015 2015 FY
Q3 2013 -2.85 -1.37 -1.26 -1145% 01 Jul 2013 30 Sep 2013 10-K 29 Jun 2015 2015 FY
Q2 2013 -1.59 -0.44 -0.33 -300% 01 Apr 2013 30 Jun 2013 10-K 29 Jun 2015 2015 FY
Q1 2013 -1.26 -0.19 -0.01 -5.6% 01 Jan 2013 31 Mar 2013 10-K 18 Jul 2013 2012 FY
Q4 2012 -1.25 -0.85 -0.57 -204% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2013 Q3
Q3 2012 -0.68 -0.11 +0.04 +27% 01 Jul 2012 30 Sep 2012 10-K 18 Jul 2013 2012 FY
Q2 2012 -0.72 -0.11 +0.11 +50% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q1
Q1 2012 -0.83 -0.18 +0.49 +73% 01 Jan 2012 31 Mar 2012 10-K 18 Jul 2013 2012 FY
Q4 2011 -1.32 -0.28 +0.37 +57% 01 Oct 2011 31 Dec 2011 10-K 18 Jul 2013 2012 FY
Q3 2011 -1.69 -0.15 +0.15 +50% 01 Jul 2011 30 Sep 2011 10-K 18 Jul 2013 2012 FY
Q2 2011 -1.84 -0.22 -0.03 -16% 01 Apr 2011 30 Jun 2011 10-K 18 Jul 2013 2012 FY
Q1 2011 -1.81 -0.67 01 Jan 2011 31 Mar 2011 10-K 02 Jul 2012 2011 FY
Q4 2010 -0.65 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2011 Q3
Q3 2010 -0.3 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q2
Q2 2010 -0.19 01 Apr 2010 30 Jun 2010 10-Q 22 Aug 2011 2011 Q1

Vistagen Therapeutics, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -1.67 -0.15 -9.9% 01 Apr 2024 31 Mar 2025 10-K 17 Jun 2025 2025 FY
2023 -1.52 +6.99 +82% 01 Apr 2023 31 Mar 2024 10-K 17 Jun 2025 2025 FY
2022 -8.51 01 Apr 2022 31 Mar 2023 10-K 11 Jun 2024 2024 FY
2015 -29.08 -18.47 -174% 01 Apr 2015 31 Mar 2016 10-K 24 Jun 2016 2016 FY
2014 -10.61 -6.8 -178% 01 Apr 2014 31 Mar 2015 10-K 24 Jun 2016 2016 FY
2013 -3.81 -3.79 -18950% 01 Apr 2013 31 Mar 2014 10-K 29 Jun 2015 2015 FY
2012 -0.02 +0.81 +98% 01 Apr 2012 31 Mar 2013 10-Q 12 Aug 2014 2014 Q1
2011 -0.83 +0.98 +54% 01 Apr 2011 31 Mar 2012 10-K 18 Jul 2013 2012 FY
2010 -1.81 01 Apr 2010 31 Mar 2011 10-K 02 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.